Viewing Study NCT00104767


Ignite Creation Date: 2025-12-25 @ 12:33 AM
Ignite Modification Date: 2025-12-31 @ 11:49 AM
Study NCT ID: NCT00104767
Status: COMPLETED
Last Update Posted: 2015-10-02
First Post: 2005-03-03
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Celecoxib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Sponsor: Jonsson Comprehensive Cancer Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module